Kim Seung Ja, Moon Woo Kyung, Kim Soo-Yeon, Chang Jung Min, Kim Sun Mi, Cho Nariya
Department of Radiology, Seoul Metropolitan Government Seoul National University, Boramae Medical Center, Seoul, Korea.
Acta Radiol. 2010 Jun;51(5):482-90. doi: 10.3109/02841851003709490.
The performance of the computer-aided detection (CAD) system can be determined by the sensitivity and false-positive marks rate, therefore these factors should be improved by upgrading the software version of the CAD system.
To compare retrospectively the performances of two software versions of a commercially available CAD system when applied to full-field digital mammograms for the detection of breast cancers in a screening group.
Versions 3.1 and 8.3 of a CAD software system (ImageChecker, R2 Technology) were applied to the full-field digital mammograms of 130 women (age range 36-80, mean age 53 years) with 130 breast cancers detected by screening.
The overall sensitivities of the version 3.1 and 8.3 CAD systems were 92.3% (120 of 130) and 96.2% (125 of 130) (P=0.025), respectively, and sensitivities for masses were 78.3% (36 of 46) and 89.1% (41 of 46) (P=0.024) and for microcalcifications 100% (84 of 84) and 100% (84 of 84), respectively. Version 8.3 correctly marked five lesions of invasive ductal carcinoma that were missed by version 3.1. Average numbers of false-positive marks per image were 0.38 (0.15 for calcifications, 0.23 for masses) for version 3.1 and 0.46 (0.13 for calcifications, 0.33 for masses) for version 8.3 (P=0.1420).
The newer version 8.3 of the CAD system showed better overall sensitivity for the detection of breast cancer than version 3.1 due to its improved sensitivity for masses when applied to full-field digital mammograms.
计算机辅助检测(CAD)系统的性能可由灵敏度和假阳性标记率来确定,因此应通过升级CAD系统的软件版本来改善这些因素。
回顾性比较一种商用CAD系统的两个软件版本应用于筛查组全视野数字化乳腺钼靶片检测乳腺癌时的性能。
将一种CAD软件系统(ImageChecker,R2 Technology)的3.1版和8.3版应用于130例经筛查发现患有130处乳腺癌的女性(年龄范围36 - 80岁,平均年龄53岁)的全视野数字化乳腺钼靶片。
3.1版和8.3版CAD系统的总体灵敏度分别为92.3%(130例中的120例)和96.2%(130例中的125例)(P = 0.025),对肿块的灵敏度分别为78.3%(46例中的36例)和89.1%(46例中的41例)(P = 0.024),对微钙化的灵敏度分别为100%(84例中的84例)和100%(84例中的84例)。8.3版正确标记出了3.1版遗漏的5例浸润性导管癌病变。3.1版每张图像的平均假阳性标记数为0.38(钙化灶为0.15,肿块为0.23),8.3版为0.46(钙化灶为0.13,肿块为0.33)(P = 0.1420)。
CAD系统的较新版本8.3在应用于全视野数字化乳腺钼靶片时,由于其对肿块的灵敏度提高,对乳腺癌检测的总体灵敏度优于3.1版。